Merck, J&J, Bristol Myers Squibb CEOs face Senate drug price hearing

Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on … Read more

Fourth-quarter earnings shaping up to be the best of 2023

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 1, 2024.  Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: the fourth-quarter is now shaping up to be the best of 2023. Despite ongoing macroeconomic concerns that have … Read more

Merck (MRK) Q4 earnings report 2023

The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021.  Andrew Kelly | Reuters Merck on Thursday reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda … Read more

J&J, Merck and Bristol Myers Squibb in the hot seat

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks … Read more

5 things to know before the stock market opens Monday

Here are the most important news items that investors need to start their trading day: 1. Rates and robots For the main factors driving stocks, there are few bigger weeks than the one ahead. The Federal Reserve, which has so far succeeded in its push to curb inflation without triggering a recession in the U.S., … Read more

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a … Read more

Fed meeting, labor report, Big Tech earnings

CNBC’s Jim Cramer on Friday looked to next week’s happenings on Wall Street, laying out how to prepare for a slew of high-profile earnings, as well as a Federal Reserve meeting and a labor report. Cramer warned that the volume of reports next week coupled with comments from the Fed will make it a tough … Read more

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | AFP | Getty Images The CEOs of Merck and … Read more

Dow goes from 37,000 to 38,000 in just 40 days. A history of the Dow and big round numbers

Stock market numbers are seen displayed at the New York Stock Exchange during afternoon trading on January 22, 2024 in New York City.  Michael M. Santiago | Getty Images News | Getty Images The Dow Jones Industrial Average crossed the 38,000 mark for the first time on Monday, just 40 calendar days after its previous … Read more

Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference

Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured so much of the growth as Abbott Labs , … Read more